FDA
-
-
-
-
-
-
-
Tandem Diabetes Care Announces Third Quarter 2025 Financial Results
-
-
-
-
-
-
-
Tandem Diabetes Care (TNDM) PT Lowered to $40 at TD Cowen
-
-
-
-
-
-
-
TANDEM DIABETES CARE, INC. (NASDAQ: TNDM) DEADLINE ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Tandem Diabetes Care, Inc.
-
-
-
-
-
-
-
Tandem Diabetes Care Completes Acquisition of Insulin Patch Pump Developer, AMF Medical
-
-
-
-
-
-
-
Tandem Diabetes Care Acquires Infusion Set Developer, Capillary Biomedical
-
-
-
-
-
-
-
Tandem Diabetes Care Announces NEJM Publication of Pediatric Study Demonstrating Increased Time-In-Range using the t:slim X2 Insulin Pump with Control-IQ Technology
-
-
-
-
-
-
-
Tandem Diabetes (TNDM) Care Announces FDA Designation of Basal-IQ Technology as Interoperable Automated Glycemic Controller
-
328,056 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

